- Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference
- Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
- Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
- Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for Global Infectious Disease Threats
- Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
- Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
- Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
More ▼
Key statistics
On Friday, Vir Biotechnology Inc (VIR:NSQ) closed at 10.70, 40.60% above the 52 week low of 7.61 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.90 |
---|---|
High | 11.00 |
Low | 10.58 |
Bid | 9.45 |
Offer | 11.11 |
Previous close | 10.66 |
Average volume | 842.60k |
---|---|
Shares outstanding | 136.06m |
Free float | 120.42m |
P/E (TTM) | -- |
Market cap | 1.46bn USD |
EPS (TTM) | -4.01 USD |
Data delayed at least 15 minutes, as of Jul 26 2024 21:00 BST.
More ▼